Publications
Publications
Show Results For
- All HBS Web
(250)
- Faculty Publications (113)
Page 1 of 113
Results →
- 2024
- Working Paper
Priceless: How to Create, Trade, and Protect What Matters Most
By: Debora L. Spar
This article explores the concept of the "sacred economy," a realm of human interactions and exchanges that transcends traditional market dynamics. It illustrates the emotional and relational aspects of human connections that cannot be quantified or traded like... View Details
- November 2024
- Teaching Note
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
Teaching Note for HBS Case No. 323-039. In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Growth and Development Strategy; Product Development; Pharmaceutical Industry; Medical Devices and Supplies Industry; United States; District of Columbia
- October 2024
- Module Note
Purpose of the Firm
By: Debora L. Spar and Julia M. Comeau
Purpose of the Firm (PoF) is a short module designed to explore how, and under what circumstances, business leaders can harness the power of capitalism and markets to “make a difference in the world”—that is, to address a significant societal problem as a commercial... View Details
- October 2024
- Teaching Note
Taiwan After Globalization: Twilight of the Developmental State?
By: Debora L. Spar and Julia M. Comeau
Teaching Note for HBS Case No. 324-032. In the last 70 years, the small island of Taiwan has achieved what many believe to be a “miracle”: its economy has grown at a record-setting pace, driven and guided by one of the world's most successful set of industrial... View Details
- August 2024 (Revised February 2025)
- Case
Novo Nordisk Foundation
By: Debora L. Spar and Julia M. Comeau
In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details
Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Profit; Corporate Governance; Business or Company Management; Corporate Social Responsibility and Impact; Expansion; Philanthropy and Charitable Giving; Nonprofit Organizations; Pharmaceutical Industry; Denmark; Europe
- March 2024 (Revised July 2024)
- Case
H2 Green Steel: A Clean-Tech Triple Play?
By: Debora L. Spar, Gunnar Trumbull, Henry Tao and Julia Comeau
At the end of 2023, the Swedish startup H2 Green Steel was mid-way through construction on an integrated steel plant in Northern Sweden that would use abundant local hydro power to create Europe’s first commercial-scale green steel. Their goal was to help European... View Details
- January 2024
- Technical Note
The ICARUS Principles: What It Takes to Tackle the World
By: Debora L. Spar and Julia M. Comeau
Over the course of the 20th century, most of the world’s major multinational corporations framed their mission around Milton Friedman’s famous mantra: that the sole purpose of the firm is to maximize its shareholders’ profits. Recently, however, growing numbers of... View Details
- December 2023 (Revised August 2024)
- Case
Monsters in the Machine? Tackling the Challenge of Responsible AI
By: Paul M. Healy and Debora L. Spar
In November of 2022, the small tech company OpenAI released ChatGPT, an artificial intelligence chatbot which quickly captured the public’s imagination—becoming the world’s fastest-growing consumer application within months of its release. Though observers from across... View Details
- November 2023 (Revised July 2024)
- Case
'Care in Every Drop': Ayala Corporation and Manila Water (A)
By: Debora L. Spar, Paul Healy, Tricia Peralta and Julia M. Comeau
Since 1834, eight generations of the Ayala family have used their conglomerate to fund nation-building projects in the Philippines, including investments in tramcars, telecommunications, hospitals, and schools. In 1997, Ayala’s subsidiary, Manila Water, took control of... View Details
- November 2023
- Supplement
'Care in Every Drop': Ayala Corporation and Manila Water (B)
By: Debora L. Spar, Paul Healy, Tricia Peralta and Julia Comeau
Since 1834, eight generations of the Ayala family have used their conglomerate to fund nation-building projects in the Philippines, including investments in tramcars, telecommunications, hospitals, and schools. In 1997, Ayala’s subsidiary, Manila Water, took control of... View Details
- October 2023
- Case
Taiwan After Globalization: Twilight of the Developmental State?
By: Debora L. Spar and Julia M. Comeau
In the last 70 years, the small island of Taiwan has achieved what many believe to be a “miracle”: its economy has grown at a record-setting pace, driven and guided by one of the world's most successful set of industrial policies, and it has become one of the richest... View Details
- March 2023
- Supplement
Halftime for Heidelberg
By: Debora L. Spar
The case follows President Rob Huntington as he seeks to find a viable way forward for Heidelberg University.
Located in Tiffin, Ohio, Heidelberg is a small, private, four-year university. As with many similar institutions of higher education, it currently faces... View Details
Located in Tiffin, Ohio, Heidelberg is a small, private, four-year university. As with many similar institutions of higher education, it currently faces... View Details
- March 2023
- Teaching Note
The Almost Nearly Perfect People: Sweden's Utopia at a Crossroads
By: Debora L. Spar and Julia Comeau
Teaching Note for HBS Case No. 322-046. View Details
- March 2023
- Teaching Note
Afrigen Biologics: Vaccines for the Global South
By: Debora L. Spar and Julia Comeau
Teaching Note for HBS Case No. 323-030. View Details
- March 2023 (Revised November 2023)
- Module Note
The Social Purpose of the Firm
By: Debora L. Spar and Julia M. Comeau
The Social Purpose of the Firm (SPF) is a short module designed to explore how, and under what circumstances, business leaders can harness the power of capitalism and markets to “make a difference in the world” – that is, to address a significant societal problem as a... View Details
- November 2022 (Revised March 2024)
- Case
Northvolt: Building Batteries to Fight Climate Change
By: George Serafeim, Debora L. Spar and Julia M. Comeau
In 2016, Swedish entrepreneurs Carl-Erik Lagercrantz and Peter Carlsson founded an electric battery company called Northvolt with the dual goals of creating a company to address climate change and bringing battery manufacture to Europe. Northvolt, which succeeded in... View Details
- November 2022 (Revised October 2024)
- Case
'A Marshall Plan for Africa': James Mwangi and Equity Group Holdings
By: Caroline M. Elkins, Debora L. Spar, Zeke Gillman and Julia M. Comeau
Financial Inclusion. Dignity. Trust. These were the core principles driving James Mwangi’s transformation of Equity Building Society, insolvent in 1991, into what is, today, Equity Group Holdings, East and Central Africa’s largest retail banking institution. Raised in... View Details
- November 2022 (Revised April 2024)
- Case
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At the time, there was little medication... View Details
- October 2022
- Case
Afrigen Biologics: Vaccines for the Global South
By: Debora L. Spar and Julia Comeau
The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details